China's SFDA send inspectors out to crackdown on counterfeiting

China's medicines watchdog, the State Food and Drug Administration), has sent a reported 80 supervisors to 33 blood-based drug manufacturers and 31 vaccine producers in 24 provinces, autonomous regions and municipalities, to crack down on the production of fake drugs (Marketletters passim).

An SFDA official said the Administration keeps a close eye on the production of blood-based drugs and vaccines to ensure their safety and effectiveness. He added that the administration will tighten supervision of the quality of human serum albumin-related medicine after a series of fake albumin medicine cases were exposed.

The SFDA began a nationwide check on the quality of albumin-related medicine at the beginning of this year and found a number of cases of fake albumin medicinal production and sales nationwide. The illegal factories have been shut down, the fake medicines recalled and criminal suspects prosecuted. In a separate case, the Guangdong Health Department found that Guangdong Bioyee Pharmaceutical had been collecting blood plasma illegally to make immunoglobulin and other drugs.